ICU Medical

ICU Medical

IV therapy systems and safety solutions

Overview

ICU Medical focuses exclusively on IV therapy across the care continuum. It develops and supplies IV therapy systems, software, and consumables designed to fit existing clinical workflows and improve patient safety and experience. Its product line includes dedicated and non-dedicated IV sets and needle-free connectors that reduce bacterial transfer, a broad range of IV smart pumps for large-volume, pain-management, and ambulatory use, and IV medication safety software that interoperates with IV-EHR systems to support safer, more efficient care. The company differentiates itself by being 100% focused on IV therapy (a result of acquiring Hospira Infusion Systems) with extensive manufacturing and supply capabilities and the broadest IV pump portfolio, enabling strong compatibility with many EHR systems. ICU Medical’s goal is to improve the safety and efficiency of IV therapy and strengthen the clinical experience for patients and caregivers.

About ICU Medical

Simplify's Rating
Why ICU Medical is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Healthcare

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Clemente, California

Founded

1984

Get referred to ICU Medical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue beat estimates, and adjusted EPS of $1.97 also beat.
  • Gross margin rose above 41%, showing simplification is improving profitability.
  • Free cash flow reached $28 million, with full-year guidance near $150 million.

What critics are saying

  • FDA approval delays can postpone hardware launches and slow replacement-cycle revenue.
  • Tariff, freight, and logistics costs pressure margins, including a $10 million 2026 headwind.
  • Vital Care exits and IV Solutions deconsolidation suppress reported revenue growth.

What makes ICU Medical unique

  • Infusion Systems and consumables grew organically in Q1 2026, led by large-volume pumps.
  • ICU Medical is exiting non-core products, concentrating on infusion therapy and profitability.
  • Its installed pump base enters a multiyear replacement cycle, supporting refresh demand.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Stock Price

Company News

AVATAR Group
Apr 2nd, 2026
Paths to precision: choosing the right vascular access device.

Paths to precision: choosing the right vascular access device. Posted on 2 April 2026 Selecting the appropriate vascular access device is crucial for effective patient care and treatment outcomes... *. ICU Medical has provided grant funding to AVATAR

ICU Medical
May 15th, 2025
ICU Medical and VisionHealth Launch MyAcapella(TM) Digital OPEP Coach to Improve OPEP Therapy and Adherence for Respiratory Patients

May 15, 2025 - ICU Medical Inc. (NASDAQ:ICUI), in collaboration with VisionHealth GmbH, has announced the launch of MyAcapella, a mobile application designed to support Oscillating Positive Expiratory Pressure (OPEP) therapy for patients with chronic respiratory conditions.

Recently Posted Jobs

Sign up to get curated job recommendations

ICU Medical is Hiring for 90 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →